{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:36:38Z","timestamp":1777181798951,"version":"3.51.4"},"reference-count":17,"publisher":"Baishideng Publishing Group Inc.","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Clin Cases"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n          <jats:p>The co-occurrence of Anti-phospholipase A2 receptor-associated membranous nephropathy (anti-PLA2R-MN) and human immunodeficiency virus (HIV) infection is a rare clinical scenario, presenting significant challenges in terms of management and treatment.<\/jats:p>\n          <jats:p>CASE SUMMARY<\/jats:p>\n          <jats:p>A 32-year-old Chinese male diagnosed with HIV infection presented with a clinical history of proteinuria persisting for over two years. A kidney biopsy demonstrated subepithelial immune complex deposition and a thickened glomerular basement membrane, indicative of stage I-II membranous nephropathy. Immunofluorescence staining revealed granular deposition of PLA2R (3+) along the glomerular capillary loops, corroborated by a strongly positive anti-PLA2R antibody test (1:320). Initial treatment involving losartan potassium, rivaroxaban, tacrolimus, and rituximab was discontinued due to either poor effectiveness or the occurrence of adverse events. Following a regimen of weekly subcutaneous injections of telitacicept (160 mg), a marked decline in the 24 h urine protein was observed within a three-month period, accompanied by a rise in serum albumin level. No significant reductions in peripheral blood CD3+CD4+T and CD3+CD8+T cell counts were detected. The patient's physical and psychological conditions showed significant improvements, with no adverse events reported during the treatment course.<\/jats:p>\n          <jats:p>CONCLUSION<\/jats:p>\n          <jats:p>Telitacicept might offer a potential therapeutic avenue for patients diagnosed with anti-PLA2R-MN concomitant with HIV infection.<\/jats:p>","DOI":"10.12998\/wjcc.v11.i22.5309","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T04:37:46Z","timestamp":1691123866000},"page":"5309-5315","source":"Crossref","is-referenced-by-count":9,"title":["Anti-phospholipase A2 receptor-associated membranous nephropathy with human immunodeficiency virus infection treated with telitacicept: A case report"],"prefix":"10.12998","volume":"11","author":[{"given":"Jin-Ling","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Ling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Xin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","published-online":{"date-parts":[[2023,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-02042-x"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.11.007"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000001220"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/v11080762"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv436"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.6211"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2021.1914655"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1857"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2017.02.004"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.10.014"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S209211"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112138-20210927-00660"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.01.012"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2021.1973493"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01591-1"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/09612033221097812"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.015"}],"container-title":["World Journal of Clinical Cases"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v11\/i22\/5309.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v11\/i22\/5309.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T11:57:03Z","timestamp":1699963023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v11\/i22\/5309.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,6]]},"references-count":17,"journal-issue":{"issue":"22"},"URL":"https:\/\/doi.org\/10.12998\/wjcc.v11.i22.5309","relation":{},"ISSN":["2307-8960"],"issn-type":[{"value":"2307-8960","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,6]]}}}